Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Colucci

Showing results (291-300 of 316) with videos related to

Pageof 32
Sort By:
Circulation Research|May 26, 2001
Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontinN A Trueblood, Z Xie, C Communal, et al.
Molecular and Cellular Biology|January 20, 2011
Mitofusin-2 maintains mitochondrial structure and contributes to stress-induced permeability transition in cardiac myocytesKyriakos N Papanicolaou, Ramzi J Khairallah, Gladys A Ngoh, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 13, 2013
SERCA Cys674 sulphonylation and inhibition of L-type Ca2+ influx contribute to cardiac dysfunction in endotoxemic mice, independent of cGMP synthesisIon A Hobai, Emmanuel S Buys, Justin C Morse, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 10, 2016
Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-αG Brunetti, F Papadia, A Tummolo, et al.
Journal of the American College of Cardiology|May 10, 2001
Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study GroupM B Fowler, M Vera-Llonch, G Oster, et al.
The New England Journal of Medicine|July 27, 2000
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study GroupW S Colucci, U Elkayam, D P Horton, et al.
Circulation|November 1, 2000
Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study InvestigatorsM T Slawsky, W S Colucci, S S Gottlieb, et al.
Circulation|October 20, 2020
Redox-Resistant SERCA [Sarco(endo)plasmic Reticulum Calcium ATPase] Attenuates Oxidant-Stimulated Mitochondrial Calcium and Apoptosis in Cardiac Myocytes and Pressure Overload-Induced Myocardial Failure in MiceJena B Goodman, Fuzhong Qin, Robert J Morgan, et al.
Circulation|February 18, 1997
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure ResearchJ N Cohn, M R Bristow, K R Chien, et al.
Journal of Cardiac Failure|October 23, 1997
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study GroupJ N Cohn, M B Fowler, M R Bristow, et al.
Pageof 32

Showing results (291-300 of 316) with videos related to

Sort By:
Pageof 32
Circulation Research|May 26, 2001
Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontinN A Trueblood, Z Xie, C Communal, et al.
Molecular and Cellular Biology|January 20, 2011
Mitofusin-2 maintains mitochondrial structure and contributes to stress-induced permeability transition in cardiac myocytesKyriakos N Papanicolaou, Ramzi J Khairallah, Gladys A Ngoh, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 13, 2013
SERCA Cys674 sulphonylation and inhibition of L-type Ca2+ influx contribute to cardiac dysfunction in endotoxemic mice, independent of cGMP synthesisIon A Hobai, Emmanuel S Buys, Justin C Morse, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 10, 2016
Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-αG Brunetti, F Papadia, A Tummolo, et al.
Journal of the American College of Cardiology|May 10, 2001
Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study GroupM B Fowler, M Vera-Llonch, G Oster, et al.
The New England Journal of Medicine|July 27, 2000
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study GroupW S Colucci, U Elkayam, D P Horton, et al.
Circulation|November 1, 2000
Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study InvestigatorsM T Slawsky, W S Colucci, S S Gottlieb, et al.
Circulation|October 20, 2020
Redox-Resistant SERCA [Sarco(endo)plasmic Reticulum Calcium ATPase] Attenuates Oxidant-Stimulated Mitochondrial Calcium and Apoptosis in Cardiac Myocytes and Pressure Overload-Induced Myocardial Failure in MiceJena B Goodman, Fuzhong Qin, Robert J Morgan, et al.
Circulation|February 18, 1997
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure ResearchJ N Cohn, M R Bristow, K R Chien, et al.
Journal of Cardiac Failure|October 23, 1997
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study GroupJ N Cohn, M B Fowler, M R Bristow, et al.
Pageof 32